About Beckley Psytech
Beckley Psytech is a company based in Oxford (United Kingdom) founded in 2019 by Cosmo Feilding Mellen and Lady Amanda Feilding.. Beckley Psytech has raised $152.62 million across 4 funding rounds from investors including Bain Capital, ATAI and Integrated. The company has 1 employees as of December 31, 2021. Beckley Psytech has completed 1 acquisition, including Eleusis. Beckley Psytech offers products and services including BPL-003 and Psychedelic Pipeline. Beckley Psytech operates in a competitive market with competitors including ATAI, COMPASS Pathways, MindMed, Cybin and Psylo, among others.
- Headquarter Oxford, United Kingdom
- Employees 1 as on 31 Dec, 2021
- Founders Cosmo Feilding Mellen, Lady Amanda Feilding
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Beckley Psytech Limited
- Date of Incorporation 02 Aug, 2018
- Jurisdiction OXFORD, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$152.62 M (USD)
in 4 rounds
-
Latest Funding Round
$50 M (USD), Series B
Jan 04, 2024
-
Investors
Bain Capital
& 11 more
-
Employee Count
1
as on Dec 31, 2021
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Beckley Psytech
Beckley Psytech offers a comprehensive portfolio of products and services, including BPL-003 and Psychedelic Pipeline. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Intranasal treatment for rapid relief in mental health disorders.
Compounds for clinical trials targeting depression and substance use.
Unlock access to complete
Funding Insights of Beckley Psytech
Beckley Psytech has successfully raised a total of $152.62M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $50 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $50.0M
-
First Round
First Round
(01 Jul 2020)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Series B - Beckley Psytech | Valuation | ATAI |
|
| Aug, 2021 | Amount | Series B - Beckley Psytech | Valuation | Integrated | |
| Dec, 2020 | Amount | Series B - Beckley Psytech | Valuation | Noetic Psychedelic Fund , Bain Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Beckley Psytech
Beckley Psytech has secured backing from 12 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Bain Capital, ATAI and Integrated. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Integrated is recognized as a venture fund focused on health transformation.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Investments are focused on alternative medicine for health solutions.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Beckley Psytech
Beckley Psytech has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Eleusis. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Immunomodulatory and neuroprotective drug candidates are developed for psychiatry needs.
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Beckley Psytech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Beckley Psytech Comparisons
Competitors of Beckley Psytech
Beckley Psytech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ATAI, COMPASS Pathways, MindMed, Cybin and Psylo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Therapies for mental disorders, including psilocybin for depression, are developed.
|
|
| domain | founded_year | HQ Location |
Psychedelic-based therapies for brain health disorders are developed.
|
|
| domain | founded_year | HQ Location |
Psychedelic therapeutics for psychiatric disorders are developed and provided.
|
|
| domain | founded_year | HQ Location |
Psychedelic-derived therapeutics for mental illnesses are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Beckley Psytech
Frequently Asked Questions about Beckley Psytech
When was Beckley Psytech founded?
Beckley Psytech was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Beckley Psytech located?
Beckley Psytech is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Who is the current CEO of Beckley Psytech?
Cosmo Feilding Mellen is the current CEO of Beckley Psytech. They have also founded this company.
Is Beckley Psytech a funded company?
Beckley Psytech is a funded company, having raised a total of $152.62M across 4 funding rounds to date. The company's 1st funding round was a Series B of $18.92M, raised on Jul 01, 2020.
How many employees does Beckley Psytech have?
As of Dec 31, 2021, the latest employee count at Beckley Psytech is 1.
What does Beckley Psytech do?
Beckley Psytech was founded in 2019 in Oxford, United Kingdom. Focus is placed on the biotechnology sector, where drugs targeting neurological and psychiatric disorders are developed. Innovative formulations of under-researched psychedelic agents are explored, alongside new chemical entities designed to enhance traditional psychedelics. These treatments address mental health and neurological conditions through clinical research and formulation efforts conducted from the UK base.
Who are the top competitors of Beckley Psytech?
Beckley Psytech's top competitors include MindMed, COMPASS Pathways and Psylo.
What products or services does Beckley Psytech offer?
Beckley Psytech offers BPL-003 and Psychedelic Pipeline.
How many acquisitions has Beckley Psytech made?
Beckley Psytech has made 1 acquisition, including Eleusis.
Who are Beckley Psytech's investors?
Beckley Psytech has 12 investors. Key investors include Bain Capital, ATAI, Integrated, Prime Movers Lab, and Delphi VC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.